CBP Discovers Finches concealed inside Hair Rollers in Guyana Man’s Baggage at JFK Airport
- Details
- Written by IVN
- Category: News
Jamaica, New York - This wasn’t the usual game of peek-a-boo, but U.S. Customs and Border Protection officers won anyway after they discovered 29 finches concealed in hair rollers inside a Guyana man’s baggage at John F. Kennedy International Airport on Sunday.
Border Patrol Agents Seize Methamphetamine and Fentanyl
- Details
- Written by IVN
- Category: News
Indio, California - El Centro Sector Border Patrol agents arrested a woman attempting to smuggle methamphetamine and fentanyl early Sunday morning.
Pittsburgh’s Pirates Possibly Peeved after CBP Seizes Shipments of Eye Patches
- Details
- Written by IVN
- Category: News
Pittsburgh, Pennsylvania - There are likely to be some perturbed plundering pirates pillaging around Pittsburgh, but U.S. Customs and Border Protection (CBP) only wants to ensure that they sack the city safely.
70 Unaccompanied Children Encountered by Border Patrol
- Details
- Written by Imperial Valley News
- Category: News
Hidalgo Texas - Rio Grande Valley Sector (RGV) Border Patrol agents recently encountered four large groups of illegal aliens.
CBP Introduces Simplified Arrival at SJU in San Juan, Puerto Rico
- Details
- Written by IVN
- Category: News
San Juan, Puerto Rico - U.S. Customs and Border Protection (CBP) in partnership with Aerostar announced the implementation of the Simplified Arrival process at the Luis Muñoz Marin International Airport (IATA: SJU, ICAO: TJSJ).
FTC Challenges Illumina’s Proposed Acquisition of Cancer Detection Test Maker Grail
- Details
- Written by IVN
- Category: News
Washington, DC - The Federal Trade Commission has filed an administrative complaint (a public version of which will be available and linked to this news release as soon as possible) and authorized a federal court lawsuit to block Illumina’s $7.1 billion proposed acquisition of Grail—a maker of a non-invasive, early detection liquid biopsy test that can screen for multiple types of cancer in asymptomatic patients at very early stages using DNA sequencing. Illumina is the only provider of DNA sequencing that is a viable option for these multi-cancer early detection, or MCED, tests in the United States.
Page 9 of 3620
- You are here:
-
Home
- News